Navigation Links
Cytokinetics Announces Non-clinical Data to be Presented at the,2007 AACR Annual Meeting

7452, a novel small molecule cardiac myosin activator, is anticipated to enter Phase II clinical trials for the treatment of heart failure in early 2007. Under a strategic alliance established in 2006, Cytokinetics and Amgen will conduct research with activators of cardiac myosin in order to identify potential treatments for patients with heart failure. Amgen has obtained an option for the joint development and commercialization of CK-1827452 exercisable during a defined period, the ending of which is dependent on Cytokinetics' conduct of further clinical trials of CK-1827452. Cytokinetics' cancer program is focused to mitotic kinesins, a family of motor proteins essential to cell division. Cytokinetics is developing two novel drug candidates that have arisen from this program, ispinesib and SB-743921, each a novel inhibitor of kinesin spindle protein (KSP), a mitotic kinesin. Ispinesib has been the subject of a broad clinical trials program comprised of nine Phase II clinical trials as well as six Phase I or Ib clinical trials. Cytokinetics plans to conduct additional clinical trials with ispinesib and is conducting a Phase I/II trial of SB-743921 in non-Hodgkin's lymphoma. Under a strategic alliance established in 2001, Cytokinetics and GlaxoSmithKline (GSK) are conducting research and development activities focused towards the potential treatment of cancer. GSK has obtained an option for the joint development and commercialization of ispinesib and SB-743921, exercisable during a defined period. Cytokinetics and GSK are conducting collaborative research activities directed to the mitotic kinesin centromere-associated protein E (CENP-E). GSK-923295, a CENP-E inhibitor, is being developed under the strategic alliance by GSK; GSK is expected to begin clinical trials with GSK-923295 in 2007. All of these drug candidates have arisen from Cytokinetics' research activities and are directed towards the cytoskeleton. The cytoskeleton is a complex biological infrastructure
'"/>




Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Cytokinetics Reports Additional Clinical Trials Data for Ispinesib
2. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
3. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
5. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
6. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
7. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
8. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
9. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
10. Protox Announces Positive Clinical Data from Prostate Cancer Study
11. Inspire Announces Webcast of Presentation at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
Post Your Comments:
(Date:7/27/2015)... , July 27, 2015  Array ... financial results for the fourth quarter and ... a conference call to discuss those results ... Chief Executive Officer will lead the call. ... Eastern TimeToll-Free:(844) 464-3927Toll:(765) 507-2598Pass Code: 68380312 Webcast, ...
(Date:7/27/2015)... Research and Markets ( http://www.researchandmarkets.com/research/4rvprn/ddimer_testing ) ... Testing Market - Global Industry Analysis, Size, Share, ... report to their offering. ... one of the fastest growing markets globally. This ... health care awareness, preference of the people for ...
(Date:7/27/2015)... , July 27, 2015 Research ... the addition of the "Wound Care ... Opportunities: 2015-2020 Analysis And Forecasts" report ... information and evaluation of the global Wound ... manufacturers, segmentation, product offerings, competitive shares, financial ...
Breaking Medicine Technology:D-dimer Testing Market - Global Industry Analysis 2015 2D-dimer Testing Market - Global Industry Analysis 2015 3Global Wound Care Markets 2015-2020 - Traditonal, Advanced And Regenerative: Competitors And Opportunities 2
... 15, 2010WHAT:A presentation on strategic collaboration opportunities ... operate as a nonprofit pharmaceutical organization and ... discovery and development capabilities – from "Idea ... at all preclinical phases of basic research, ...
... of two devices could save the lives of ... implemented nationwide, suggests results of a clinical trial ... Symposium. A significantly higher percentage of patients who ... compression decompression cardiopulmonary resuscitation (ACD CPR) performed with ...
Cached Medicine Technology:SRI International Executive Walter Moos to Discuss Collaborative Pharmaceutical Opportunities with a Nonprofit Organization at BIO-Europe 2010 2SRI International Executive Walter Moos to Discuss Collaborative Pharmaceutical Opportunities with a Nonprofit Organization at BIO-Europe 2010 3NIH-Funded Study Is First to Demonstrate Increased Long-Term Survival With Favorable Neurologic Function Among Patients Receiving CPR Using ACSI ResQPump™ and ResQPOD® CPR Devices 2NIH-Funded Study Is First to Demonstrate Increased Long-Term Survival With Favorable Neurologic Function Among Patients Receiving CPR Using ACSI ResQPump™ and ResQPOD® CPR Devices 3
(Date:7/27/2015)... (PRWEB) , ... July 28, 2015 , ... Almost a ... plans to offer behavioral health counseling for persons who are obese and those who ... was less clear. , That mandate will affect any commercial health plan with a ...
(Date:7/27/2015)... NY (PRWEB) , ... July 28, 2015 , ... ... a 2015-2016 inductee into the NAPW VIP Woman of the Year Circle. She is ... and over 200 operating Local Chapters, NAPW is the nation’s leading networking organization exclusively ...
(Date:7/27/2015)... ... July 27, 2015 , ... The heroin epidemic is affecting the ... on July 7th. The rate for heroin usage has continued to climb around ... and is a less expensive alternative for those with an addiction to prescription opiate ...
(Date:7/27/2015)... ... July 27, 2015 , ... Looking to brush up ... Blue Cross Blue Shield of New Jersey has enhanced its Dental webpage with new ... of their teeth. , “Horizon is committed to offering our 3.8 million members ...
(Date:7/27/2015)... ... July 27, 2015 , ... David Gilmour has added ... performing for one additional night at each of his original four tour stops in ... savings. , David Gilmour’s 2016 North America tour dates: , Thursday, March 24, 2016 ...
Breaking Medicine News(10 mins):Health News:How Digital Therapeutics Can Help Payers Out of Regulatory Fix 2Health News:How Digital Therapeutics Can Help Payers Out of Regulatory Fix 3Health News:NAPW Inducts Deana Skidmore, Assistant Director of Nursing at Wilton Meadows Rehablilitation and Health Care Center, Into its VIP Woman of the Year Circle 2Health News:45% Of People Addicted to Heroin Began Addicted to Prescription Medications 2Health News:45% Of People Addicted to Heroin Began Addicted to Prescription Medications 3Health News:Thinking about a Dental Check-up? Check out Horizon Blue Cross Blue Shield of New Jersey’s Enhanced Website for a Dental Download of Helpful Information 2Health News:Cheap David Gilmour Tickets at Madison Square Garden (MSG), Air Canada Center, United Center and Hollywood Bowl: Additional Dates for David Gilmour Go On Sale Today 2
... the All India Institute of Medical Sciences, was Wednesday ... cardiology department as per the directions of the Delhi ... the cardio-thoracic surgery department, will replace Venugopal. ... Minister Ambumani Ramadoss, who is also president of the ...
... CD containing information on almost 3 million residents of Georgia, ... have been lost in transit//. , The CD is ... of people who were enrolled in Medicaid or PeachCare, a ... preceding June 2006. , Affiliated Computer Services (ACS), ...
... heavy-handed on the salt. This, researchers say is dangerous simply ... developing the deadly stroke. ,Based on data garnered ... Canadians far exceeded the recommended limits of sodium consumption- 2300 ... aged one to three. , It was seen ...
... their body with dietary supplements, without any proof of ... spent by Americans annually on dietary supplements with the ... and extend life. ,Research conducted on ... cardiovascular health. Ginkgo biloba, another dietary supplement boasts of ...
... Chhattisgarh is reeling under a heat wave with day ... of Korba and Raigarh shooting// up to 42 degrees ... the industrial town of Korba. In Raipur, people preferred ... ,The metrological department has forecast a further ...
... in the Health department of the much-vaunted New York ... with rats to continue to function. ... resigned Monday. ,The infestation, which was captured ... enforcement of health code rules at city eateries. Only ...
Cached Medicine News:Health News:Canadians Consuming Too Much Salt 2Health News:Officials Indicted for Allowing a Fast Food Joint Teeming With Rats in New York to Function 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: